Personal information

Activities

Collapse all

Works (3)

Carboplatin-induced upregulation of pan β-tubulin and class III β-tubulin is implicated in acquired resistance and cross-resistance of ovarian cancer

Cellular and Molecular Life Sciences
2023-10 | Journal article
DOI: 10.1007/s00018-023-04943-0
Contributors: Margareta Pernar Kovač; Vanja Tadić; Juran Kralj; George E. Duran; Alessia Stefanelli; Darija Stupin Polančec; Sanja Dabelić; Niko Bačić; Maja T. Tomicic; Petra Heffeter et al.
Source: check_circle
Crossref

Targeting YB-1 via entinostat enhances cisplatin sensitivity of pleural mesothelioma in vitro and in vivo

Cancer Letters
2023-10 | Journal article
DOI: 10.1016/j.canlet.2023.216395
Contributors: Karin Schelch; Dominik Emminger; Benjamin Zitta; Thomas G. Johnson; Verena Kopatz; Sebastian Eder; Alexander Ries; Alessia Stefanelli; Petra Heffeter; Mir A. Hoda et al.
Source: check_circle
Crossref

Thiosemicarbazone Derivatives Developed to Overcome COTI-2 Resistance

Cancers
2022-09-14 | Journal article
DOI: 10.3390/cancers14184455
Contributors: Vivien Pósa; Alessia Stefanelli; Julia H. Bormio Nunes; Sonja Hager; Marlene Mathuber; Nóra V. May; Walter Berger; Bernhard K. Keppler; Christian R. Kowol; Éva A. Enyedy et al.
Source: check_circle
Crossref
How many people are using ORCID?